Walleye Capital
EXAS

Walleye Capital’s Exact Sciences EXAS Stock Holding History

Walleye Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,500
Closed -$965K – 4567
2025
Q4 		$965K Sell
9,500
-9,300
-49% -$747K ﹤0.01% 2461
2025
Q3 		$1.03M Buy
18,800
+17,500
+1,346% +$874K ﹤0.01% 2072
2025
Q2 		$69.1K Sell
1,300
-8,400
-87% -$427K ﹤0.01% 3929
2025
Q1 		$420K Sell
9,700
-10,300
-52% -$522K ﹤0.01% 2695
2024
Q4 		$1.12M Sell
20,000
-18,800
-48% -$1.17M ﹤0.01% 2287
2024
Q3 		$2.64M Buy
38,800
+18,400
+90% +$1.04M 0.01% 1693
2024
Q2 		$862K Buy
20,400
+18,000
+750% +$990K ﹤0.01% 3003
2024
Q1 		$166K Sell
2,400
-6,100
-72% -$386K ﹤0.01% 4091
2023
Q4 		$629K Sell
8,500
-24,900
-75% -$1.63M ﹤0.01% 2760
2023
Q3 		$2.28M Buy
33,400
+8,900
+36% +$755K 0.01% 1627
2023
Q2 		$2.3M Buy
24,500
+13,700
+127% +$1.07M 0.01% 1239
2023
Q1 		$732K Buy
10,800
+3,900
+57% +$251K 0.01% 1384
2022
Q4 		$342K Sell
6,900
-10,300
-60% -$421K 0.01% 1699
2022
Q3 		$559K Buy
+17,200
New +$709K 0.01% 1384
2020
Q2 		– Sell
-8,500
Closed -$493K – 719
2020
Q1 		$493K Sell
8,500
-1,800
-17% -$146K 0.11% 230
2019
Q4 		$953K Sell
10,300
-28,100
-73% -$2.47M 0.06% 438
2019
Q3 		$3.47M Buy
38,400
+16,300
+74% +$1.86M 0.21% 99
2019
Q2 		$2.61M Buy
22,100
+4,900
+28% +$494K 0.29% 55
2019
Q1 		$1.49M Buy
+17,200
New +$1.46M 0.25% 87

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Walleye Capital's EXAS Position: Q1 2026 in Review

Walleye Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,396 shares — an estimated $1.16M sold.

Walleye Capital first reported a position in EXAS in Q1 2019 and held it in 19 quarters. The position peaked at $5.43M in Q3 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Walleye Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 11,396 Exact Sciences shares in Q1 2026, an estimated $1.16M.
  • Walleye Capital first reported a position in Exact Sciences in Q1 2019 and held it in 19 quarters.
  • Walleye Capital's Exact Sciences position peaked at $5.43M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.